AMGEN TO PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE

Core Insights - Amgen will present at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025, featuring executives Peter Griffith and Kave Niksefat [1] - The webcast of the presentation will be available for media, investors, and the public, and will be archived for at least 90 days [2] Company Overview - Amgen is a leader in biotechnology, focusing on discovering, developing, manufacturing, and delivering innovative medicines for serious diseases [3] - The company has a robust pipeline aimed at treating cancer, heart disease, osteoporosis, inflammatory diseases, and rare diseases [3] - In 2024, Amgen received accolades such as being named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes [4] - Amgen is part of the Dow Jones Industrial Average and the Nasdaq-100 Index, highlighting its significance in the market [4]